Rejection, Transplant Completed Phase 4 Trials for Caffeine (DB00201)

Also known as: Transplant Rejection / Transplant rejections / Graft Rejection

IndicationStatusPhase
DBCOND0030946 (Rejection, Transplant)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01766050Study to Evaluate Effect of Belatacept on Pharmacokinetics of Inje Cocktail in Healthy VolunteersBasic Science